Bomi is an international group working on the logistics and management of high-technology products for health protection.
Bomi’s experience in the biomedical field allows us to safeguard and optimize the performance of the supply chain of our clients. To do so, we draw on our extensive expertise in the sector and adhere to the highest quality standards: from in vitro diagnostics to large pieces of equipments for medical imaging, orthopaedic surgery devices to diagnostic kits, devices for the management of chronic conditions to nanotechnology, we cover every service need for every medical device on the market.
Bomi Peru
In response to several years of growth of the Peruvian healthcare industry, and consequently to the increasing demand on specialized logistics services, BOMI PERU was incorporated in January 2014.
Considering the present need of high logistics services standards, as well as the potential future growth of the healthcare sector, we have located our warehouse within the logistic complex “Portada de Lurin” in Punta Hermosa, Lima, only 25 minutes South of the city. This location allows us to efficiently serve any destination within Lima, and has the space available to accommodate our growth according to our customers’ needs.
Contact details
WAREHOUSE
Centro Logístico Portada de Lurín
Almacén G05
Carretera Panamericana Sur Km. 38
Punta Hermosa, Lima, Peru
OFFICE
Monte Rosa 255, 4°piso
Lima 33, Peru
+51 1 615 0750
www.bomigroup.com/en/peru
Bomi Peru was incorporated in January 2014, amidst a number of new openings of the Italian logistics company. Andres Vazquez, commercial director, traces the evolution of the affiliate over the…
Many of the multinational companies with a long-standing presence in Latin America used to have factories in Peru – since the 1990s all of these companies have closed their facilities…
In modern terms, Peru’s healthcare system was largely underdeveloped for many years; but the economic fortune that Peru has experienced in more recent years has allowed for a significant overhaul…
Rodrigo Fernandez became country president of AstraZeneca Central America, Caribbean, and Middle Andean Countries (CAMCARMAC) in July 2013. He discusses the challenges across the region for regulation and distribution channels,…
Akhilesh Vijay came to Accord Healthcare Peru following a career at Intas Pharmaceutical in India. He urges the implementation of regulation for Biosimilars and discusses his strategy for future growth…
Seguro Integral de Salud (SIS) is the social protection scheme run under Peru’s Ministry of Health designed to provide health services to the country’s unemployed and poverty-stricken citizens. Its leader,…
Eurofarma entered the Peruvian market in 2013 through the acquisition of local player Refasa-Carrión. Rómulo García, the affiliate’s ambitious general manager, discusses the merge and his quest to become a…
Cesar Amaro, director general of Digemid, highlights the evolution of Peru’s recently-established regulatory agency while taking into account the challenges surrounding the institution on a daily basis, like approval times,…
Erbe Elektromedizin established its Peruvian representative office in 2013, the first in Latin America. Juan Otiniano, director of the affiliate, discusses the startup process and the importance of educating government…
Bomi Peru was incorporated in January 2014, amidst a number of new openings of the Italian logistics company. Andres Vazquez, commercial director, traces the evolution of the affiliate over the…
Induquímica is the only Peruvian pharmaceutical company with the “Marca Peru” emblem, a result of the company’s extremely high quality. General Manager Christian Quintanilla talks about the company’s success, and…
Luis Pinillos and Carlos Vallejos both served as Directors of INEN, the Cancer Institute and Minister of Health during President Garcia’s administrations. They discuss the achievements made before, during and…
Carolina López-Torres joined Hospira Peru in 2011 following a dynamic career at Novartis. She discusses the early challenges she faced and the opportunities that the government’s hospital expansion plan has…
See our Cookie Privacy Policy Here